403 related articles for article (PubMed ID: 27000374)
1. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment.
García-Mendoza MG; Inman DR; Ponik SM; Jeffery JJ; Sheerar DS; Van Doorn RR; Keely PJ
Breast Cancer Res; 2016 May; 18(1):49. PubMed ID: 27169366
[TBL] [Abstract][Full Text] [Related]
3. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
[TBL] [Abstract][Full Text] [Related]
4. Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
Hallett MA; Teng B; Hasegawa H; Schwab LP; Seagroves TN; Pourmotabbed T
Breast Cancer Res; 2013 Feb; 15(1):R12. PubMed ID: 23407024
[TBL] [Abstract][Full Text] [Related]
5. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
6. Hic-5 remodeling of the stromal matrix promotes breast tumor progression.
Goreczny GJ; Ouderkirk-Pecone JL; Olson EC; Krendel M; Turner CE
Oncogene; 2017 May; 36(19):2693-2703. PubMed ID: 27893716
[TBL] [Abstract][Full Text] [Related]
7. Deletion of
Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
[TBL] [Abstract][Full Text] [Related]
8. Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice.
Hara T; Murakami Y; Seiki M; Sakamoto T
Biochem Biophys Res Commun; 2017 Aug; 490(3):688-692. PubMed ID: 28634075
[TBL] [Abstract][Full Text] [Related]
9. IL-25 blockade inhibits metastasis in breast cancer.
Jiang Z; Chen J; Du X; Cheng H; Wang X; Dong C
Protein Cell; 2017 Mar; 8(3):191-201. PubMed ID: 27909985
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
Wang S; Yuan Y; Liao L; Kuang SQ; Tien JC; O'Malley BW; Xu J
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):151-6. PubMed ID: 19109434
[TBL] [Abstract][Full Text] [Related]
11. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
13. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.
Werbeck JL; Thudi NK; Martin CK; Premanandan C; Yu L; Ostrowksi MC; Rosol TJ
Vet Pathol; 2014 Jul; 51(4):868-81. PubMed ID: 24091811
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer.
Giles ED; Jindal S; Wellberg EA; Schedin T; Anderson SM; Thor AD; Edwards DP; MacLean PS; Schedin P
Breast Cancer Res; 2018 Jun; 20(1):50. PubMed ID: 29898754
[TBL] [Abstract][Full Text] [Related]
16. A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis.
Wang W; Meng Y; Dong B; Dong J; Ittmann MM; Creighton CJ; Lu Y; Zhang H; Shen T; Wang J; Rowley DR; Li Y; Chen F; Moore DD; Yang F
Neoplasia; 2017 May; 19(5):421-428. PubMed ID: 28433771
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model.
Liu R; Zheng H; Li W; Guo Q; He S; Hirasaki Y; Hou W; Hua B; Li C; Bao Y; Gao Y; Qi X; Pei Y; Zhang Y
J Transl Med; 2015 Nov; 13():366. PubMed ID: 26597177
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.
Boyle ST; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model.
Tran-Thanh D; Buttars S; Wen Y; Wilson C; Done SJ
Cancer Prev Res (Phila); 2010 Feb; 3(2):202-11. PubMed ID: 20103725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]